Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Muctarr Sesay
Advertisement
Muctarr Sesay, PhD, is chief scientific officer and vice-president of Bioconjugation at Goodwin Biotechnology.
Articles by Muctarr Sesay
Bioconjugation chemistry is the joining of biomolecules to other biomolecules, small molecules, and polymers by chemical or biological means.
Advertisement
Latest Updated Articles
Monoclonal Antibody Conjugation via Chemical ModificationPublished: December 1st 2003 | Updated:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Weekly News Roundup—Week of Oct. 13, 2025
2
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
3
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
4
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
5
